IP Verse

Sarepta Therapeutics competitive analysis

Latest oppositions filed by Sarepta Therapeutics

Explore patent oppositions filed by Sarepta Therapeutics against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 3, 2026
Patent NumberTitleApplicantOpposition Date
EP3018211
Antisense Nucleic AcidsNATIONAL CENTER OF NEUROLOGY AND PSYCHIATRYMay 6, 2020
EP2636741
Induction Of Exon Skipping In Eukaryotic CellsACADEMISCH ZIEKENHUIS LEIDENJan 27, 2017
EP2602322
Induction Of Exon Skipping In Eukaryotic CellsACADEMISCH ZIEKENHUIS LEIDENDec 1, 2016
EP2594640
Induction Of Exon Skipping In Eukaryotic CellsACADEMISCH ZIEKENHUIS LEIDENSep 29, 2016
EP2594641
Induction Of Exon Skipping In Eukaryotic CellsACADEMISCH ZIEKENHUIS LEIDENSep 29, 2016
EP2594642
Induction Of Exon Skipping In Eukaryotic CellsACADEMISCH ZIEKENHUIS LEIDENSep 29, 2016

Latest PTAB cases involving Sarepta Therapeutics

Discover the latest PTAB cases involving Sarepta Therapeutics, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 4, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Sarepta Therapeutics

IPR2026-00270Feb 26, 2026SAREPTA THERAPEUTICSGENZYMEInstitution Denied
IPR2026-00166Dec 2, 2025SAREPTA THERAPEUTICSGENZYMETerminated
IPR2026-00167Dec 2, 2025SAREPTA THERAPEUTICSGENZYMEInstitution Denied
IPR2026-00168Dec 2, 2025SAREPTA THERAPEUTICSGENZYMEInstitution Denied
IPR2026-00149Nov 25, 2025SAREPTA THERAPEUTICSGENZYMEInstitution Denied
IPR2026-00150Nov 25, 2025SAREPTA THERAPEUTICSGENZYMETrial Instituted
IPR2025-01194Jun 26, 2025SAREPTA THERAPEUTICSGENZYMEDiscretionary Denial
IPR2025-01195Jun 26, 2025SAREPTA THERAPEUTICSGENZYMEDiscretionary Denial
IPR2024-00580Feb 21, 2024SAREPTA THERAPEUTICSTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAFinal Written Decision - Appealed
IPR2021-01134Jun 21, 2021SAREPTA THERAPEUTICSNATIONAL CENTER OF NEUROLOGY AND PSYCHIATRYTerminated

Peer Comparison New

IP litigation analysis comparing Sarepta Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SAREPTA THERAPEUTICS6 - 16 -
ACADEMISCH ZIEKENHUIS LEIDEN - 12 - -
GENZYME129211
NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY - 2 - 7